Champions Oncology, Inc.
NASDAQ:CSBR · NASDAQ Capital Market
-$0.08 today
Vol 0.00M · Avg 0.01M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-21.59%
Period High
$8.91
Period Low
$5.64
Latest
$6.32
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Sutro Biopharma, Inc.
NASDAQ:STRO
$287.03M
Artiva Biotherapeutics, Inc.
NASDAQ:ARTV
$236.33M
Shattuck Labs, Inc.
NASDAQ:STTK
$231.97M
Oramed Pharmaceuticals Inc.
NASDAQ:ORMP
$155.72M
InflaRx N.V.
NASDAQ:IFRX
$130.74M
Connect Biopharma Holdings Limited
NASDAQ:CNTB
$126.24M
Kalaris Therapeutics Inc
NASDAQ:KLRS
$89.68M
Atara Biotherapeutics, Inc.
NASDAQ:ATRA
$88.71M
ImageneBio Inc
NASDAQ:IMA
$67.79M
Metagenomi, Inc. Common Stock
MGX
$45.74M
What is the latest CSBR filing?
The latest filing shown is 8-K dated Mar 30, 2026.
How many recent filings does CSBR have?
Intrinsic Alpha currently shows 20 recent filings for CSBR.
Explore More
Continue the stock analysis
Jump to another research area for this company.